¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"effective conjugate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • avidin-antigen conjugate
    ¾ÆºñµòÇ׿øÁ¢ÇÕü
  • binocular conjugate optomotor reflex
    µÎ´«°øµ¿¿îµ¿¹Ý»ç
  • conjugate
    1. µ¿Çâ-, ÄÓ·¹- 2. ¾ÕµÚÁö¸§, °áÇÕ°æ 3. Á¢ÇÕü, °áÇÕ
  • conjugate alkali
    ¦¾ËÄ®¸®
  • conjugate axis
    °áÇÕÃà, ÄÓ·¹Ãà
  • conjugate base
    ¦¿°±â
  • conjugate bilirubin
    °áÇÕºô¸®·çºó
  • conjugate deviation
    µ¿ÇâÆíÀ§, °øµ¿ÆíÀ§
  • conjugate diameter
    ¾ÕµÚÁö¸§, °áÇÕ°æ
  • conjugate gaze
    µ¿ÇâÁÖ½Ã, °øµ¿ÁÖ½Ã
  • conjugate movement
    µ¿Çâ¿îµ¿, ÄÓ·¹¿îµ¿
  • conjugate point
    1. ÄÓ·¹Á¡ 2. °áÇÕÁ¡
  • diagonal conjugate
    ºø¾ÕµÚÁö¸§, ´ë°¢°áÇÕ°æ
  • diagonal conjugate diameter
    ºø¾ÕµÚÁö¸§, ´ë°¢°áÇÕ°æ
  • external conjugate diameter
    ¹Ù±ù¾ÕµÚÁö¸§, ¿Ü°áÇÕ°æ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective dose
    À¯È¿¿ë·®, À¯È¿¼±·®
  • effective demand
    À¯È¿¼ö¿ä
  • effective blood volume
    À¯È¿Ç÷¾×·®
  • conjugate
    1.¾ÕµÚÁö¸§, ÄÓ·¹, 2.Á¢ÇÕü, °áÇÕ
  • diagonal conjugate
    ºø¾ÕµÚÁö¸§
  • obstetrical conjugate
    Ãâ»ê¾ÕµÚÁö¸§
  • true conjugate
    Âü¾ÕµÚÁö¸§, Áø°áÇÕ¼±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • avidin-antigen conjugate
    ¾ÆºñµòÇ׿øÁ¢ÇÕü
  • conjugate alkali
    ¦¿°±â
  • conjugate axis
    °áÇÕÃà, ÄÓ·¹Ãà
  • binocular conjugate optomotor reflex
    µÎ´«°øµ¿¿îµ¿¹Ý»ç
  • conjugate base
    ¦¿°±â
  • conjugate bilirubin
    °áÇÕºô¸®·çºó
  • conjugate
    ¾ÕµÚÁö¸§-, ÄÓ·¹-, Á¢ÇÕü
  • conjugate deviation
    µ¿ÇâÆíÀ§, °øµ¿ÆíÀ§
  • conjugate diameter
    ºø¾ÕµÚÁö¸§
  • conjugate gaze
    µ¿ÇâÁÖ½Ã, °øµ¿ÁÖ½Ã
  • conjugate movement
    µ¿Çâ¿îµ¿, ÄÓ·¹¿îµ¿
  • conjugate point
    ÄÓ·¹Á¡, °áÇÕÁ¡
  • conjugate solution
    ¦¿ë¾×
  • enzyme-antibody conjugate
    È¿¼ÒÇ×üÁ¢ÇÕü
  • fluorescein conjugate
    Ç÷ç¿À·¹¼¼ÀÎÁ¢ÇÕü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phase conjugate symmetry
    À§»ó ȸº¹ ´ëĪ (À§»ó °ø¾× ´ëĪ)
  • read conjugate symmetry
    ÆÇµ¶ °ø¾× ´ëĪ
  • EAV=£¾effective alveolar ventilation
    À¯È¿ÆóÆ÷ȯ±â(·®).
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®, Áß°£À¯È¿·®.
  • ED 50=£¾effective dose 50%
    50% À¯È¿·®.
  • ELBF=£¾effective liver blood flow
    À¯È¿¼º °£Ç÷·ù.
  • ELBF=£¾effective liver blood flow
    À¯È¿ °£Ç÷·ù.
  • EPNDB =effective perceived noise level
    ½ÇÈ¿°¨¼ö¼ÒÀ½·¹º§, ½ÇÁ¦°¨°¢¼ÒÀ½
  • ERPF => effective renal plasma flow
    À¯È¿½ÅÇ÷ÀåÀ¯Åë·®
  • ERPF=£¾effective renal plasma flow
    À¯È¿½ÅÇ÷·ù·®.
  • MED => minimum effective dose
    ÃÖ¼ÒÈ«¹Ý·®
  • MED=> minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • MED=£¾minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • avidin-antigen conjugate
    ¾Æºñµò-Ç׿ø¹èÇÕü
  • binocular conjugate optomotor reflex
    ¾ç¾È°øµ¿¿îµ¿¹Ý»ç
  • conjugata =conjugate diameter<³ª>
    ÀüÈÄÁ÷°æ, (Áø)°áÇÕ¼±(òØÌ¿ùêàÊ).
  • conjugate acid
    °áÇÕ»ê(Ì¿ùêß«)
  • conjugate acid
    ¦»ê(¡­ß«).
  • conjugate alkali
    °áÇÕ¿°±â
  • conjugate axis
    °áÇÕÃà(Ì¿ùêõî).»ý¸®ÄÓ·¹Ãà, °ø¾×Ãà(Íìäùõî).
  • conjugate base
    ¦¿°±â(¡­ç¤Ñ¨).
  • conjugate deviation
    µ¿ÇâÆíÀ§, °øµ¿ÆíÀ§
  • conjugate diameter
    ÄÓ·¹Áö¸§, °áÇÕÁö¸§. °ø¾×Áö¸§.
  • conjugate diameter
    ¾ÕµÚÁö¸§
  • conjugate double bond
    ÀÌÁß°áÇÕ(ì£ñì Ì¿ùê).
  • conjugate element
    ÄÓ·¹¿ø¼Ò, °ø¾×¿ø¼Ò(ÍìäùêªáÈ).
  • conjugate gaze
    µ¿ÇâÁÖ½Ã, °øµ¿ÁÖ½Ã
  • conjugate movement
    µ¿Çâ¿îµ¿, °øµ¿¿îµ¿(¡­ê¡ÔÑ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Conjugate diameter
    ¾ÕµÚÁö¸§
    [¿¾ ¿ë¾î] Áø°áÇÕ¼±
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conjugate acid-base pair
    ¦ÁöÀº »ê¿°±â½Ö(ß«ç¤Ðñäª)
  • conjugate redox couple
    ¦ÁöÀº »êȭȯ¿ø(ß«ûùü½êª)¦ (ÔÒ) redox couple
  • effective concentration
    À¯È¿ ³óµµ (êóüùÒØÓø)
  • effective half-life
    À¯È¿ ¹Ý°¨±â(êóüùÚâÊõÑ¢)
  • effective lethal phase
    À¯È¿ Ä¡»ç±â(êóüùöÈÞÝÑ¢)
  • folic acid conjugate
    Æú»ê(ß«) Æ÷ÇÕü(øÙùêô÷)
  • median effective dose
    Á¤Áß À¯È¿·®(ïáñéêóüùÕá)
  • steroid conjugate
    ½ºÅ×·ÎÀ̵å Á¢ÇÕü(ïÈùêô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conjugate
    ÄÓ·¹, °ø¾×, °áÇÕ¼±, ¹èÇÕü
  • effective half life
    À¯È¿¹Ý°¨±â
  • effective TR
    À¯È¿¹Ýº¹½Ã°£
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®
  • phase conjugate symmetry
    À§»óȸº¹´ëĪ, À§»ó°ø¾×´ëĪ
  • read conjugate symmetry
    ÆÇµ¶°ø¾×´ëĪ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EC effective concentration; ejection click; electrochemical; electron capture; embryonal carcinoma; eme...
AERP antegrade effective refractory period; atrial effective refractory period
ESP early systolic paradox; echo spacing; effective sensory projection; effective systolic pressure; end...
MEC median effective concentration; middle ear canal; middle ear cell; minimum effective concentration
MLF Median Longitudinal Fasciculus
  Role; links the CN III Nucleus with Contralateral CN ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CLEM Conjugate Lateral Eye Movement
PHP Pyridoxalated haemoglobin polyoxyethylene conjugate
WGA-HRP Wheat germ agglutinin-horseradish peroxidase conjugate
ACCESS Access to Community Care and Effective Services and Support
AERP Atrial effective refractory period
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • conjugate acid
    ¦»ê
    °ø¾×¿°±â¿¡ ¾ç ÀüÀÚ¸¦ ÷°¡ÇÏ¿© Çü¼ºÇÑ È­ÇÐ ¹°Áú.
  • conjugate double bond
    ÀÌÁß °áÇÕ
  • conjugate movement
    °ø¾× ¿îµ¿
  • conjugate point
    °ø¾× Á¡, ÄÓ·¹ Á¡, °áÇÕ Á¡
  • conjugate solution
    ¦ ¿ë¾×
  • hapten-protein conjugate
    ÇÕÅÙ ´Ü¹é °áÇÕ¹°
  • lateral conjugate paralysis
    Ãø¹æ ½Ã ¸¶ºñ
  • paralysis of conjugate movement
    °øµ¿ ¿îµ¿ ¸¶ºñ
  • read conjugate symmetry
    ÆÇµ¶ °ø¾× ´ëĪ
  • committed effective dose equivalent
    ¿¹Å¹ À¯È¿ ¼±·® ´ç·®
  • effective
    À¯È¿ÇÑ
    ÀǵµµÈ °á°ú¸¦ ÀÏÀ¸Å³ ¼ö ÀÖ´Â.
  • effective arterial volume
    À¯È¿ µ¿¸ÆÇ÷·®
  • effective blood volume
    À¯È¿ Ç÷¾×·®
  • effective diameter
    À¯È¿ Áö¸§
  • effective dose 50%
    Áß°£ À¯È¿·®, 50% À¯È¿·®
    µ¿¹°¿¡ µ¶¼Ò³ª ¾à¹° Åõ¿© ½Ã, 50%ÀÇ µ¿¹°¿¡¼­ À¯È¿ÇÏ´Ù°í ÃßÁ¤µÇ´Â ¿ë·®.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
effective conjugate The internal conjugate measured from the nearest lumbar vertebra to the symphysis, in spondylolisthesis.
Synonym: false conjugate.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
aperture, effective <microscopy> The diameter of the entrance pupil: it is the apparent diameter of the limiting aperture measured from the front.
(05 Aug 1998)
renal blood flow, effective The amount of blood flowing to the parts of the kidney that are involved with the production of constituents of urine. It is that portion of the total renal blood flow that perfuses functional renal tissue (e.g., the glomeruli). It should be differentiated from renal plasma flow, effective which is based on the amount of plasma rather than on total renal blood.
(12 Dec 1998)
median effective dose The dose that produces the desired effect; when followed by a subscript (generally "ED50"), it denotes the dose having such an effect on a certain percentage (e.g., 50%) of the test animals; ED50 is the median effective dose, in radiation protection, the sum of the equivalent doses in all tissues and organs of the body weighted for tissue effects of radiation. The unit of effective dose is the sievert (Sv), epilation dose, the minimum amount of radiation sufficient to produce hair loss, usually in 10 to 14 days.
(05 Mar 2000)
cost-effective A term describing a resource that is available within the time it is needed and is able to meet or reduce electrical power demand at an estimated incremental system cost no greater than that of the least-costly, similarly reliable and available alternative.
(05 Dec 1998)
effective Producing the intended result.
(18 Nov 1997)
effective collision radius <radiobiology> Effective size of a particle equal to the square root of (cross-section/pi). Determines the effective range of interaction of the particle.
(09 Oct 1997)
effective dose The dose that produces the desired effect; when followed by a subscript (generally "ED50"), it denotes the dose having such an effect on a certain percentage (e.g., 50%) of the test animals; ED50 is the median effective dose, in radiation protection, the sum of the equivalent doses in all tissues and organs of the body weighted for tissue effects of radiation. The unit of effective dose is the sievert (Sv), epilation dose, the minimum amount of radiation sufficient to produce hair loss, usually in 10 to 14 days.
(05 Mar 2000)
effective half-life <radiobiology> Time required for a radioactive substance contained in a biological system (such as a person or an animal) to reduce its radioactivity by half, as a combination result of radioactive decay and biological elimination from the system.
(09 Oct 1997)
effective osmotic pressure That part of the total osmotic pressure of a solution that governs the tendency of its solvent to pass across a boundary, usually a semipermeable membrane; it is commonly represented by the product of the total osmotic pressure of the solution and the ratio (corrected for activities) of the number of dissolved particles that do not permeate the bounding membrane to the total number of particles in the solution; equivalent in meaning to tonicity; commonly expressed in equivalent units of osmolality rather than pressure per se.
(05 Mar 2000)
effective refractory period The period during which impulses may appear but are too weak to be conducted; the longest interval between adequate stimuli, falling just short of the time necessary to allow a propagated response to be evoked in a tissue by the second stimulus; it differs from the functional refractory period in that it is a measure of stimulus interval rather than response interval of time.
(05 Mar 2000)
effective renal blood flow The amount of blood flowing to the parts of the kidney that are involved with production of constituents of urine.
(05 Mar 2000)
effective renal plasma flow <physiology> The amount of plasma flowing to the parts of the kidney that have a function in the production of constituents of urine; the clearance of substances such as iodopyracet and p-aminohippuric acid, assuming that the extraction ratio in the peritubular capillaries is 100%.
It is the amount of plasma perfusing the kidney tubules per unit time, generally measured by p-aminohippurate clearance. It should be differentiated from renal plasma flow which is approximately 10% greater than the effective renal plasma flow.
(07 Mar 2000)
effective temperature A comfort index or scale which takes into account the temperature of air, its moisture content, and movement.
(05 Mar 2000)
effective temperature index A composite index of environmental comfort which is compared after exposure to different combinations of air temperature, humidity, and movement.
(05 Mar 2000)
vaccines, conjugate Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognised by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conjugate
    ¸¦ Ȱ¿ë½ÃŰ´Ù
  • conjugate
    Ȱ¿ë(º¯È­)½ÃŰ´Ù;Ȱ¿ë(º¯È­)ÇÏ´Ù;°áÇÕÇÏ´Ù;°áÈ¥ÇÏ´Ù;Á¢ÇÕ(±³¹Ì)ÇÏ´Ù;(¦À¸·Î)°áÇÕÇÑ;Á¢ÇÕÀÇ;ÇÑ Â¦À» ÀÌ·ç´Â(ÀÙ);¾î¿øÀÌ °°Àº;µ¿±ÙÀÇ;°ø¾×±ÙÀÇ;¾î¿øÀÌ °°Àº ¸»;°ø¾×;-gative();-gator()
  • effective
    È¿°úÀûÀÎ
  • cost-effective
    ºñ¿ëÈ¿À²ÀûÀÎ
  • effective
    À¯È¿ÇÑ;È¿°úÀûÀÎ;ÀλóÀûÀÎ;»ç½Ç»óÀÇ;½ÇÁ¦ÀÇ;È¿·ÂÀÖ´Â;µ¿¿ø°¡´ÉÇÑ;º´·Â;´«¿¡ ¶ç´Â
  • effective aperture
    (±¤)(·»ÁîÀÇ) À¯È¿ ±¸°æ
  • effective demand
    (°æ)À¯È¿ ¼ö¿ä
  • effective exchange rate
    (±ÝÀ¶)½ÇÈ¿ ȯ½Ã¼¼(ȯÀ²)(±¹Á¦ÅëÈ­±â±ÝÀÌ ´çÇØ±¹°ú ´Ù¸¥ ÁÖ¿ä 20°³±¹ ÅëÈ­ÀÇ È¯½Ã¼¼¸¦ º¹ÇÕ½ÃÄÑ »êÃâÇÏ´Â Áö¼ö)
  • effective money (coin)
    °æÈ­
  • effective range
    (°ø)À¯È¿ »ç°Å¸®(»çÁ¤)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á